These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8515290)

  • 1. Control of intracellular growth of Mycobacterium fortuitum by human monocytes in vitro.
    Nziramasanga P; Shah PM; Stille W
    J Chemother; 1993 Apr; 5(2):103-6. PubMed ID: 8515290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the susceptibility in vitro of 54 isolates of Mycobacterium fortuitum against three fluoroquinolones using two methods.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Apr; 7(2):109-13. PubMed ID: 7666115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
    Wallace RJ; Bedsole G; Sumter G; Sanders CV; Steele LC; Brown BA; Smith J; Graham DR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):65-70. PubMed ID: 2327761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H; Sato K; Tomioka H; Dekio S
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa.
    Smith RP; Baltch AL; Franke MA; Michelsen PB; Bopp LH
    J Antimicrob Chemother; 2000 Apr; 45(4):483-8. PubMed ID: 10747825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
    Callegan MC; Booth MC; Gilmore MS
    Cornea; 2000 Jul; 19(4):539-45. PubMed ID: 10928774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J; Mormède M; Fourche J; Bébéar C
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
    Van Caekenberghe D
    J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains].
    Aysev AD
    Mikrobiyol Bul; 1993 Jan; 27(1):31-5. PubMed ID: 8421440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.
    Gillespie SH; Basu S; Dickens AL; O'Sullivan DM; McHugh TD
    J Antimicrob Chemother; 2005 Aug; 56(2):344-8. PubMed ID: 15956099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B; Coban AY; Durupinar B
    J Chemother; 2001 Dec; 13(6):661-3. PubMed ID: 11806630
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.